Small-Cap REIT ETF ...
Health Care: Drugs
Amicus Therapeutics Inc. (FOLD: NASDAQ)
$3.43 0.06 | 1.78%
05/17/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 33.97M | 25.67M | 29.57M | 19.34M |
| Receivables | 3.22M | 5.04M | 0.00 | 0.00 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 104.62M | 66.65M | 109.68M | 80.49M |
| Property, Plant & Equipment, Gross | 13.53M | 11.94M | 10.70M | 10.74M |
| Accumulated Depreciation & Depletion | 8.50M | 9.51M | 8.10M | 6.34M |
| Property, Plant & Equipment, Net | 5.03M | 2.44M | 2.60M | 4.40M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 442.00K | 709.00K | 267.00K | 485.00K |
| Total Non-Current Assets | 5.47M | 3.15M | 2.87M | 4.88M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 110.09M | 69.80M | 112.55M | 85.37M |
| Accounts Payable | 8.84M | 2.58M | 8.29M | 9.64M |
| Short Term Debt | 398.00K | 1.04M | 1.29M | 1.56M |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 9.24M | 19.26M | 16.22M | 11.19M |
| Long Term Debt | 299.00K | 0.00 | 1.04M | 2.30M |
| Deferred Income Taxes | 30.42M | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 908.00K | 20.95M | 30.35M | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 31.62M | 20.95M | 31.40M | 2.34M |
| Total Liabilities | 40.87M | 40.20M | 47.62M | 13.54M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 69.22M | 29.59M | 64.93M | 71.83M |
| Common Par | 556.00K | 407.00K | 406.00K | 287.00K |
| Additional Paid In Capital | 387.54M | 299.28M | 290.25M | 242.26M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -318.89M | -270.10M | -225.69M | -170.76M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 14.00K | 4.00K | -28.00K | 43.00K |
| Total Capitalization | 69.52M | 29.59M | 65.98M | 74.13M |
| Total Equity | 69.22M | 29.59M | 64.93M | 71.83M |
| Total Liabilities & Stock Equity | 110.09M | 69.80M | 112.55M | 85.37M |
| Total Common Shares Outstanding | 49.63M | 34.65M | 34.51M | 22.67M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 45.57M | 34.57M | 27.73M | 22.62M |
| Diluted Weighted Shares Outstanding | 45.57M | 34.57M | 27.73M | 22.62M |
| Number of Employees | 112 | 96 | 99 | 97 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with FOLD
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserWatchlist
- ContributorStocks With Big Insider Buy...
- Contributor22 Biopharma Stocks With Br...
Latest FOLD Headlines from TheStreet
- Amicus Therapeutics Announces Full-Year 2012 Financial Results And Corporate Updates 03.12.13 | 04:03 pm
- Amicus Therapeutics To Announce Full-Year 2012 Financial Results On March 12, 2013 03.07.13 | 07:03 am
- Amicus Therapeutics Introduces Proprietary "CHART" Platform Technology 03.04.13 | 07:03 am
- Amicus Therapeutics To Present At Cowen And Company 33rd Annual Health Care Conference 02.27.13 | 04:02 pm
- A Legit Reason To Give Amicus' Fabry Drug Another Chance 02.19.13 | 06:02 am
- Amicus Therapeutics Presents Additional 6-Month Results From Phase 3 Fabry Monotherapy Study At LDN World Symposium 02.15.13 | 10:02 am
- Amicus Therapeutics Advances Chaperone-Enzyme Replacement Therapy (ERT) Combination Platform In Pompe Disease 02.14.13 | 07:02 am
- Amicus Therapeutics Presents Additional Results From Phase 2 Chaperone-Enzyme Replacement Therapy (ERT) Study For Fabry Disease At LDN World Symposium 02.13.13 | 08:02 am
- 3 Biotech Stocks Under $10 Moving Higher 02.12.13 | 02:02 pm
- Amicus Therapeutics Announces Posters And Presentations At Lysosomal Disease Network WORLD Symposium 02.07.13 | 03:02 pm
Press Releases for FOLD
- Amicus Therapeutics Joins Russell 3000® Index - PR Newswire 06.27.11 | 09:06 am
- Amicus Therapeutics To Present At Jefferies 2011 Global Healthcare Conference On Tuesday, June 7, 2011 - PR Newswire 05.31.11 | 09:05 am
- Amicus Therapeutics Announces Transition Of John F. Crowley From Chairman And Chief Executive Officer To Executive Chairman - PR Newswire 04.18.11 | 04:04 pm
- Amicus Therapeutics To Present At The 13th Annual BIO CEO And Investor Conference On Tuesday, February 15, 2011 - PR Newswire 02.10.11 | 08:02 am
- Amicus Therapeutics Initiates Phase 2 Clinical Trial Evaluating Amigal⢠Co-administered With Enzyme Replacement Therapy - PR Newswire 02.09.11 | 07:02 am
- Amicus Therapeutics To Host Its Third Quarter 2010 Financial Results Conference Call And Webcast On November 8, 2010 - PR Newswire 11.02.10 | 08:11 am
- Amicus Therapeutics To Host Conference Call And Webcast To Discuss Exclusive Worldwide Agreement With GSK To Develop And Commercialize Amigal⢠For Fabry Disease - PR Newswire 10.29.10 | 06:10 am
- Amicus Therapeutics To Present At The BIO Investor Forum On October 5, 2010 - PR Newswire 09.30.10 | 08:09 am
- Amicus Therapeutics To Present At The Canaccord Genuity 30th Annual Growth Conference On August 12, 2010 - PR Newswire 08.04.10 | 08:08 am
- Amicus Therapeutics To Host Its Second Quarter 2010 Financial Results Conference Call And Webcast On August 5, 2010 - PR Newswire 07.27.10 | 08:07 am
Partner Headlines for FOLD
- Curing Parkinson's: The Alternative Approach - Is There Money To Be Made? - Seeking Alpha 04.04.13 | 09:04 am
- After-Hours Earnings Report for March 12, 2013 : KW, DOLE, ACAD, GCA, GNMK, AVID, WSR, KTOS, GERN, ACRX, FOLD, GCAP - NASDAQ 03.12.13 | 06:03 pm
- Mid-Week Biopharma Catalyst Trades To Consider - Seeking Alpha 12.13.12 | 09:12 am
- Glaxo Invests in Nigeria - Analyst Blog - Zacks 11.28.12 | 09:11 am
- 5 Bio-Pharmas On The Rise With Potential Groundbreaking And Lifesaving Treatments - Seeking Alpha 10.09.12 | 09:10 am
- 3 Best Biotech Stocks For This Week (Part V) - Seeking Alpha 10.08.12 | 09:10 am
- Glaxo Aims to Expand Synflorix Label - Analyst Blog - NASDAQ 09.19.12 | 03:09 pm
- Glaxo Increases Stake in RGDX - Analyst Blog - NASDAQ 09.18.12 | 09:09 pm
- Glaxo to Increase Stake in Amicus - Analyst Blog - Zacks 07.19.12 | 06:07 pm
- Healthcare Business Review: Somaxon Goes WILD, Amicus's Great DEAL - Wall St. Cheat Sheet 07.19.12 | 08:07 am
